Treo Ventures

Treo Ventures operates as a specialized venture capital firm, focusing its investments on breakthrough medical device and digital health innovations. The firm’s approach centers on identifying and supporting solutions with the potential to significantly impact human life, particularly those addressing large unmet needs within the healthcare sector. They primarily deploy capital into companies situated across the United States and Europe, leveraging their deep industry expertise to foster advancement in critical areas.

The firm was established in 2018 by Founding General Partners Mudit Jain and Brad Vale. Their combined experience forms the bedrock of Treo Ventures; Mudit Jain previously held positions with Johnson & Johnson’s venture arm, JJDC, and Synergy Life Science Partners, while Brad Vale formerly led JJDC. This foundation led to the insight that there was a critical need for focused investment in medical technology and digital health to accelerate impactful solutions.

Treo Ventures’ portfolio companies develop products for a broad spectrum of patients facing significant medical challenges, aiming to improve their quality of life and clinical outcomes. The firm’s overarching vision is to transform the healthcare landscape by strategically funding and nurturing companies that are developing revolutionary medical devices and digital health technologies, ultimately working towards a future where innovative solutions readily address pressing global health concerns.